Status:

COMPLETED

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA

Lead Sponsor:

LG Chem

Conditions:

Osteoarthritis, Knee

Eligibility:

All Genders

40-80 years

Phase:

PHASE1

PHASE2

Brief Summary

This study is a multi-center, randomized, placebo-controlled, double-blind clinical study, consisting of Part 1 (Phase 1b) in a sequential, dose-escalating design and Part 2 (Phase 2) in a parallel de...

Eligibility Criteria

Inclusion

  • Patients diagnosed with primary osteoarthritis of the knee according to the ACR clinical criteria, with Kellgren-Lawrence grade 2 to 3 in the corresponding knee as determined in the X-ray test
  • Patients with pain in the index knee requiring NSAIDs or analgesics which sustained for at least 6 months
  • Patients with a score of ≥ 4 and ≤ 9 in response to question 1 (walking pain) on the WOMAC pain subscale (11-point NRS)
  • Patients with the subtotal score of ≥ 20 and ≤ 45 on the WOMAC pain subscale (11- point NRS)
  • Patients with BMI at or below 40 kg/m2

Exclusion

  • Patients with chronic pain requiring continuous treatment
  • Patients with rheumatoid arthritis or other inflammatory arthritis
  • Patients with skin disorders at the administration site
  • Patients with clinically significant renal or cardiovascular disease or those with suspected SARS-CoV-2 infection
  • Patients in a medical condition which may affect the efficacy and/or safety assessment
  • Patients with Kellgren-Lawrence grade 4 in the contralateral knee
  • Patients with tense effusion
  • Patients having administered an opioid analgesic/ other analgesic/health functional foods, single dose of IA injection within a certain period prior to drug administration
  • Patients having undergone knee replacement

Key Trial Info

Start Date :

April 27 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 11 2024

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT05237752

Start Date

April 27 2022

End Date

March 11 2024

Last Update

May 3 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Emeritus Research

Camberwell, Australia

2

The Catholic Univ. of Korea Seoul St. Mary's Hospital

Seoul, South Korea